A new study from OHSU is claiming to show promise in the treatment of what they are calling an "urgent, unmet need" in cancer ...

Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...

A nationwide clinical trial shows positive results for cancer patients with this common wasting syndrome. Researchers discovered a drug that safely and effectively helped cancer patients when they ...

Researchers discovered a drug that safely and effectively helped cancer patients when they suffered from cachexia (ku-KEK-see-uh), a common condition related to cancer that involves weight loss and ...

Researchers discovered a drug that safely and effectively helped cancer patients when they suffered from cachexia (ku-KEK-see ...

Cachexia is a wasting syndrome prevalent in cancer patients (as well as patients with other conditions) that is marked by weight loss, loss of muscle mass, fatigue, and lack of appetite, and is ...

The experimental drug ponsegromab is a monoclonal antibody that treats the growth factor that leads to the growth of cancer ...

Cancer patients frequently experience metabolic dysfunction, leading to severe weight loss correlating with a poor prognosis.

Maxim Group analyst Jason McCarthy maintained a Buy rating on Artelo Biosciences (ARTL – Research Report) yesterday and set a price ...

Jamie Theakston revealed he has stage one laryngeal cancer. For many people the first noticeable symptom is a sore throat, ...

A phase 2 trial of ponsegromab has shown promising results in treating cancer cachexia, a condition that leads to severe weight and muscle loss, according to a study published Sept. 14 in the New ...